Murray International Recalls Unapproved Sciatica Pills Marketed as Supplements
Murray International Trading Co. is recalling 144 bottles of Sciatica Pills because they are marketed as dietary supplements but contain drug claims, making them unapproved drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the rubric specifies that FDA Class II recalls with significant injury/property-damage reports or structural defects are Severe. While specific injury reports are not detailed in the snippet, the unapproved drug status and Class II designation align with the Severe criteria for significant regulatory violations involving unapproved pharmaceuticals.
Plain-English summary
Murray International Trading Co., Inc. is recalling 144 bottles of Sciatica Pills. The product is packaged in 120-count bottles within a box, made in the People's Republic of China, and features labeling that includes Chinese characters. The recall covers all lots of the product.
The recall was initiated because the products are marketed as dietary supplements but bear labeling with drug and disease claims. This classification makes them unapproved drugs, as they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The product was distributed nationwide and in Puerto Rico. Consumers who possess this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- SCIATICA PILLS, packaged in 120-count bottles within a box, Made in the Peoples Republic of China, remaining labeling contains Chinese characters.
- Manufacturer
- Murray International Trading Co., Inc.
- Category
- Drug — Unapproved Drug
- Affected units
- 144
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Part of a larger recall action
This product is one of 14 recalled by Murray International Trading Co., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Murray International Trading Co., Inc.
See all →- HighHerbal Doctor Angelicae Sinensis Recalled for Elevated Lead and Cadmium
FDA (Food) · 2021-12-08
- ModerateGastrodia Capsules Recalled for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateMurray International Trading Recalls Farser Kai Yeung Pill for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- SevereFUCONPO Capsule Recalled for Marketing Without Approved NDA or ANDA
FDA (Drugs) · 2016-07-20
- ModerateMurray International Recalls Unapproved Flucinonide Ointment Cream
FDA (Drugs) · 2016-07-20
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04